Literature DB >> 10710100

In vitro activity of rifabutin against strains of Helicobacter pylori resistant to metronidazole and clarithromycin.

A Pilotto, M Franceschi, M Rassu, F Furlan, M Scagnelli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10710100     DOI： 10.1111/j.1572-0241.2000.01900.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  13 in total

1.  Efficacy and tolerability of rifampicin-based rescue therapy for Helicobacter pylori eradication failure in peptic ulcer disease.

Authors:  Vineet Ahuja; Vikram Bhatia; S Dattagupta; Akshay Raizada; Mahesh Prakash Sharma
Journal:  Dig Dis Sci       Date:  2005-04       Impact factor: 3.199

Review 2.  Third-line rescue therapy for Helicobacter pylori infection.

Authors:  Rossella Cianci; Massimo Montalto; Franco Pandolfi; Giovan-Battista Gasbarrini; Giovanni Cammarota
Journal:  World J Gastroenterol       Date:  2006-04-21       Impact factor: 5.742

3.  In vitro activity of clarithromycin against intracellular Helicobacter pylori.

Authors:  R Piccolomini; G Di Bonaventura; C Picciani; F Laterza; J Vecchiet; M Neri
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

4.  Current Paradigm and Future Directions for Treatment of Helicobacter pylori Infection.

Authors:  Jason Ferreira; Steven F Moss
Journal:  Curr Treat Options Gastroenterol       Date:  2014-12

5.  Diagnosis and Treatment of Helicobacter pylori.

Authors:  Mae F Go
Journal:  Curr Treat Options Gastroenterol       Date:  2005-04

6.  Rifaximin Plus Levofloxacin-Based Rescue Regimen for the Eradication of Helicobacter pylori.

Authors:  Sang-Pil Yun; Han Gyung Seon; Chang Soo Ok; Kwang Ho Yoo; Min Kyung Kang; Won Hee Kim; Chang Il Kwon; Kwang Hyun Ko; Seong Gyu Hwang; Pil Won Park; Sung Pyo Hong
Journal:  Gut Liver       Date:  2012-10-18       Impact factor: 4.519

Review 7.  Attempts to enhance the eradication rate of Helicobacter pylori infection.

Authors:  Chang Seok Bang; Gwang Ho Baik
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

Review 8.  Role of Helicobacter pylori infection in gastric carcinogenesis: Current knowledge and future directions.

Authors:  Aleksandra Sokic-Milutinovic; Tamara Alempijevic; Tomica Milosavljevic
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

9.  Alternative eradication regimens for Helicobacter pylori infection in Indonesian regions with high metronidazole and levofloxacin resistance.

Authors:  Muhammad Miftahussurur; Langgeng Agung Waskito; Ari Fahrial Syam; Iswan Abbas Nusi; Gontar Siregar; Marselino Richardo; Achmad Fuad Bakry; Yudith Annisa Ayu Rezkitha; I Dewa Nyoman Wibawa; Yoshio Yamaoka
Journal:  Infect Drug Resist       Date:  2019-01-31       Impact factor: 4.003

10.  Efficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infection.

Authors:  José M Navarro-Jarabo; Nuria Fernández; Francisca L Sousa; Encarnación Cabrera; Manuel Castro; Luz M Ramírez; Robin Rivera; Esther Ubiña; Francisco Vera; Isabel Méndez; Francisco Rivas-Ruiz; José L Moreno; Emilio Perea-Milla
Journal:  BMC Gastroenterol       Date:  2007-07-25       Impact factor: 3.067
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.